23andMe Holding Co Class A ME
Find similar stocks with Morningstar Investor.
Morningstar analysts do not currently cover ME, but with our powerful screener, you can find stocks in the same sector, industry, or style and filter on our unbiased ratings and valuation metrics.
News
-
23andMe Launches New Genetic Report on Bipolar Disorder
-
23andMe and the Colorectal Cancer Alliance Collaborate to Help Advance Colorectal Cancer Research in the Black Community
-
23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting
-
Largest study on the LRRK2 variant leads to discoveries about health, ancestry, and history
-
23andMe Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
-
Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals
-
23andMe to Report Q4 and Full Year FY2024 Financial Results
-
Potter Handy Law Firm Represents Nearly 5,000 Clients in 23andMe Data Breach Case
Trading Information
- Previous Close Price
- $0.42
- Day Range
- $0.39–0.42
- 52-Week Range
- $0.35–2.04
- Bid/Ask
- $0.41 / $0.42
- Market Cap
- $198.11 Mil
- Volume/Avg
- 4.4 Mil / 5.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.88
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 582
- Website
- https://www.23andme.com
Comparables
Valuation
|
Metric
|
ME
|
FLGT
|
ACRS
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 1.05 | 0.54 | 0.51 |
Price/Sales | 0.88 | 2.11 | 2.30 |
Price/Cash Flow | — | 20.44 | — |
Price/Earnings
ME
FLGT
ACRS
Financial Strength
|
Metric
|
ME
|
FLGT
|
ACRS
|
|---|---|---|---|
Quick Ratio | 1.77 | 4.81 | 3.86 |
Current Ratio | 2.01 | 5.09 | 4.16 |
Interest Coverage | — | −3,451.87 | — |
Quick Ratio
ME
FLGT
ACRS
Profitability
|
Metric
|
ME
|
FLGT
|
ACRS
|
|---|---|---|---|
Return on Assets (Normalized) | −29.26% | −0.46% | −36.39% |
Return on Equity (Normalized) | −41.04% | −0.50% | −47.28% |
Return on Invested Capital (Normalized) | −37.37% | −1.73% | −47.18% |
Return on Assets
ME
FLGT
ACRS
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Rckpvpmlht | Xbwz | $221.8 Bil | |||
| Danaher Corp
DHR
| Kxsmsbnnp | Wfsghy | $194.9 Bil | |||
| IDEXX Laboratories Inc
IDXX
| Cwyshsypg | Kzwmsdr | $41.1 Bil | |||
| IQVIA Holdings Inc
IQV
| Gxmjrvgmk | Mlrmlx | $39.9 Bil | |||
| Agilent Technologies Inc
A
| Njmrdsst | Jmpb | $38.8 Bil | |||
| Mettler-Toledo International Inc
MTD
| Fwdlfllgg | Bflgbft | $30.7 Bil | |||
| Icon PLC
ICLR
| Bmsbhxdf | Vjkzv | $26.4 Bil | |||
| Illumina Inc
ILMN
| Pprdmkq | Vbzrk | $18.1 Bil | |||
| Waters Corp
WAT
| Hjvwnwrfx | Yfvmn | $17.9 Bil | |||
| Labcorp Holdings Inc
LH
| Scqnzhzt | Sfmmpc | $16.6 Bil |